Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Patients With Moderately to Severely Active Ulcerative Colitis”

8 trials

Showing 8 of 8 results

Testing effectiveness (Phase 2)Looking for participantsNCT07229950
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

Who this might be right for
Adult Patients With Moderately to Severely Active Ulcerative Colitis
Shandong Suncadia Medicine Co., Ltd. 66
Testing effectiveness (Phase 2)Looking for participantsNCT06598943
What this trial is testing

Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 140
Not applicableActive Not RecruitingNCT05817942
What this trial is testing

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Alfasigma S.p.A. 509
Not applicableLooking for participantsNCT06764706
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Early research (Phase 1)Not Yet RecruitingNCT06754891
What this trial is testing

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Inflammatory Bowel Diseases
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 116
Testing effectiveness (Phase 2)Ended earlyNCT04677179
What this trial is testing

LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Nektar Therapeutics 81
Testing effectiveness (Phase 2)Looking for participantsNCT07232576
What this trial is testing

Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis

Who this might be right for
Adult Patients With Moderately to Severely Active Ulcerative Colitis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Post-approval studies (Phase 4)Looking for participantsNCT06095128
What this trial is testing

Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Takeda 65

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation